Latest Capital Management News

Latitude Group Holdings has lodged a replacement prospectus for its Capital Notes 2 offer, revealing an increased offer size and updated margin following a completed bookbuild.

Pro Medicus Limited has announced an on-market buy-back program targeting up to 10% of its ordinary shares, aiming to return capital to shareholders without requiring approval.

European Lithium Limited has closed its initial on-market share buy-back and announced a new six-month program to repurchase shares at a discount, aiming to enhance shareholder value by reducing capital.

Hansen Technologies has updated its dividend announcement, specifying a DRP price of AUD 5.08 per share alongside a fully franked 5 cent dividend for the half-year ending December 2025.

Challenger Limited has welcomed APRA’s new capital framework for longevity products, set to ease capital requirements and reduce risk for providers, supporting Australia’s evolving retirement income market.

Centuria Office REIT has successfully refinanced $1 billion of debt, reducing margins by around 30 basis points and extending debt maturity to 4.3 years, with no expiries until FY29. This move signals strong lender confidence amid a volatile interest rate environment.

West African Resources forecasts a record 430,000 to 490,000 ounces of gold production in 2026, driven by full-year output from Kiaka and sustained performance at Sanbrado. The company plans significant drilling and capital investment to extend mine life and enhance growth.

Auric Mining Limited reported a near doubling of net profit to $5.2 million for 2025, marking its successful transition to a gold producer with key operational milestones at Munda and the acquisition of Burbanks processing facility.

Iluka Resources has set the allocation price for shares issued under its 2025 final dividend DRP at $6.3449, resulting in the issuance of over 41,000 new shares to participating shareholders.

Shriro Holdings has introduced a new dividend policy aiming to distribute 20-30% of net profit after tax annually, balancing shareholder returns with capital needs. The Board retains discretion over payments, factoring in franking credits and strategic priorities.

Botanix Pharmaceuticals has successfully renegotiated its API supply agreement, deferring significant purchases to later years and strengthening its financial position ahead of Sofdra's market rollout.

Alkane Resources has locked in a $110 million revolving credit facility alongside a $40 million contingent instrument facility, enhancing liquidity and banking ties to support its mining operations and growth projects.